Fredrick Ferris, MD
Internal Medicine · St Paul, MNNPI 1316953854
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,290 of the $6,252 with a category attached, or 84.6%. Sanofi US Services Inc. accounts for 84.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $5,339 and has fallen 99.7% since, to $17 in 2025. Among internal medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $94.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$5K
- Amgen$236
- Novo Nordisk$133
- Kowa Pharmaceuticals America, Inc.$88
- Johnson & Johnson$83
- Pfizer$47
- plus $374 from 17 others
What the payments were for
- Consulting fees$5,29085%
- Food & beverage$95015%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 1 | $5,290 |
| Amgen | 15 | $236 |
| Novo Nordisk | 9 | $133 |
| Kowa Pharmaceuticals America, Inc. | 6 | $88 |
| Johnson & Johnson | 6 | $83 |
| Pfizer | 4 | $47 |
| Novartis | 2 | $42 |
| Merck | 3 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| AstraZeneca | 2 | $28 |
| Lilly USA, LLC | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Philips North America LLC | 2 | $25 |
| Itamar Medical Inc | 1 | $21 |
| Bayer | 1 | $19 |
| Bio Products Laboratory USA, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Exact Sciences | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| CSL Behring | 1 | $12 |
How this compares
$6,252 in reported general payments places this provider in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 40 | $49,932 |
| XareltoRivaroxaban | 31 | $40,608 |
| TrulicityDulaglutide | 28 | $32,456 |
| EliquisApixaban | 25 | $21,425 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $19,161 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $14,151 |
| MounjaroTirzepatide | 11 | $11,827 |
| Lacosamide | 12 | $4,005 |
| Memantine Hcl ErMemantine Hcl | 25 | $2,768 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,336 |
| Atorvastatin Calcium | 136 | $1,715 |
| Metoprolol Succinate | 80 | $1,606 |
| CholestyramineCholestyramine (With Sugar) | 16 | $1,599 |
| Bupropion XlBupropion Hcl | 46 | $1,593 |
| SynthroidLevothyroxine Sodium | 13 | $1,532 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $15 | $49,93240 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $27 | $44,28339 claims |
| Johnson & JohnsonXarelto | $83 | $40,60831 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $13 | $33,31145 claims |
| PfizerEliquis | $47 | $21,42525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Other internal medicine in St Paul
- Gregory PolandRochester$494K
- Thomas MartensBrooklyn Center$158K
- Roy ChoMinneapolis$122K
- Kamran AfzalFridley$69K
- Ekta KapoorRochester$55K
- Luke SeaburgRochester$55K
- Robert PignoloRochester$52K
- Jaskanwal Deep SaraSaint Paul$50K
- Mustafa ArainMinneapolis$44K
- Noah WillifordMinneapolis$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.